FDA
-
-
-
-
-
-
-
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026
-
-
-
-
-
-
-
SeaStar Medical Announces 2026 Milestones
-
-
-
-
-
-
-
SeaStar Medical (ICU) Announces Appointment of Michael Messinger as CFO
-
-
-
-
-
-
-
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
-
-
-
-
-
-
-
SeaStar Medical enrolls 125 patients in kidney injury trial
-
-
-
-
-
-
-
SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry
-
-
-
-
-
-
-
EXECUTIVE INTERVIEW: SeaStar CMO And Pediatric Specialist Talk About Promising Therapy To Treat Pediatric AKI
-
323,715 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

